デフォルト表紙
市場調査レポート
商品コード
1547051

味覚マスキング用医薬品添加剤市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Pharmaceutical Excipients For Taste Masking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 175 Pages
納期
2～5営業日
カスタマイズ可能
味覚マスキング用医薬品添加剤市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年08月27日
発行: Persistence Market Research
ページ情報: 英文 175 Pages
納期: 2～5営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界の味覚マスキング用医薬品添加剤市場に関する包括的なレポートを発表しました。当レポートでは、促進要因・動向・機会・課題などの重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • 味覚マスキング用医薬品添加剤市場規模（2024年）：9億8,560万米ドル
  • 予測市場金額（2033年）：15億3,920万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：5.1%

味覚マスキング用医薬品添加剤市場：調査範囲

味覚マスキング用医薬品添加剤は、医薬品の製剤化において重要な役割を果たし、不快な味や臭いをマスキングすることで患者のコンプライアンスを向上させます。これらの添加剤は、医薬品の選好性を高めるために、錠剤、シロップ剤、粉末剤など様々な剤形にわたって使用されています。同市場は製薬メーカー、医薬品開発業務受託機関（CRO）、医薬品製造業務受託機関（CMO）を対象としており、香料、甘味料、コーティング材を含むさまざまな添加剤を提供しています。

市場成長の促進要因：

味覚マスキング用医薬品添加剤の世界市場は、患者の服薬アドヒアランスを向上させるために効果的な味覚マスキングソリューションが必要とされる小児用医薬品や高齢者用医薬品の需要の高まりなど、いくつかの重要な要因に後押しされています。経口投与薬に対する消費者の選好の高まりや、新しい味覚マスキング剤や高度なコーティング材料の開発といった添加剤技術の進歩が、市場の拡大をさらに後押ししています。一般用医薬品（OTC）分野の成長と個別化医療への関心の高まりも、革新的な味覚マスキングソリューションの需要に貢献しています。

市場抑制要因：

有望な成長見通しにもかかわらず、味覚マスキング用医薬品添加剤市場は、高度な添加剤技術の高コストと規制上のハードルに関連する課題に直面しています。添加剤の安全性と有効性を規定する厳しい規制は、メーカーにコンプライアンス上の負担を課し、運用コストを増加させます。さらに、特定の製剤に使用できる味覚マスキングソリューションが限られていることや、新規添加剤を開発するための継続的な研究開発投資が必要であることも、市場開拓の課題となっています。

市場機会：

味覚マスキング用医薬品添加剤市場は、技術革新、人口動向、進化する製剤によって大きな成長機会がもたらされます。ナノテクノロジーやポリマーベース添加剤などの先端技術の統合は、味覚マスキング効果を高め、市場成長の新たな道を開きます。さらに、新興国市場の医薬品産業の拡大と患者中心の医薬品開拓の重視の高まりは、市場プレーヤーにとって費用対効果が高く効率的な味覚マスキングソリューションを導入する好機となります。戦略的パートナーシップ、研究開発への投資、ユーザーフレンドリーな添加剤の採用は、新たな機会を活用し、ダイナミックな味覚マスキング市場においてリーダーシップを維持するために不可欠です。

本レポートで扱う主要な質問

  • 味覚マスキング用医薬品添加剤市場の世界の成長を促進する主要な要因は何か？
  • どの添加剤の種類と用途が、さまざまな医薬製剤で味覚マスキングの採用を促進しているか？
  • 技術的進歩は味覚マスキング用医薬品添加剤市場の競合情勢をどのように変えているのか？
  • 味覚マスキング用医薬品添加剤市場に貢献している主要企業はどこか？
  • 世界の味覚マスキング用医薬品添加剤市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 添加剤のイノベーション / 開発動向

第4章 主要な成功要因

  • 製品の採用 / 使用状況分析
  • 製品のUSP / 特徴
  • 最近の製品承認と発売
  • パイプライン評価
  • PESTLE分析
  • ポーターの分析
  • 規制シナリオ

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • ダイナミクス

第6章 COVID-19危機 - 影響評価

  • COVID-19と影響分析
    • 添加剤別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 地域別
  • 2023年の市場シナリオ

第7章 世界市場の需要（金額または規模、百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 世界市場分析：添加剤別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：添加剤別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：添加剤別、2024年～2033年
    • 天然
    • 人工
    • 栄養価の高い
    • 栄養価のない
    • ポリオール
    • その他
  • 市場の魅力分析：添加剤別

第9章 世界市場分析：技術別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：技術別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析と予測：技術別、2024-2033年
    • ホットメルト押出成形
    • マイクロカプセル化
    • コーティング
    • 官能検査法
    • その他
  • 市場の魅力分析：技術別

第10章 世界市場分析：使用法別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：使用法別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：使用法別、2024年～2033年
    • 固形剤形
    • 液体剤形
  • 市場の魅力分析：使用法別

第11章 世界市場分析：エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：エンドユーザー別、2024年～2033年
    • 医薬品
    • 栄養補助食品
    • 契約製造組織
  • 市場の魅力分析：エンドユーザー別

第12章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模（百万米ドル）の分析：地域別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 市場の魅力分析：地域別

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 南アジア市場分析

第17章 東アジア市場分析

第18章 オセアニア市場分析

第19章 中東・アフリカ市場分析

第20章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • ブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • SPI Pharma, Inc.
    • Adare Pharmaceutical Inc.
    • GPT Pharmaceuticals Pvt. Ltd
    • Roquette Freres
    • Rochem International, Inc.
    • Gattefose
    • Asahi Kasei Corporation
    • DuPont de Nemours, Inc
    • Dow Pharma Solutions

第22章 使用される前提条件と頭字語

第23章 調査手法

目次
Product Code: PMRREP14743

Persistence Market Research has recently released a comprehensive report on the worldwide Pharmaceutical Excipients for Taste Masking Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Pharmaceutical Excipients for Taste Masking Market Size (2024E): USD 985.6 million
  • Projected Market Value (2033F): USD 1,539.2 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.1%

Pharmaceutical Excipients for Taste Masking Market - Report Scope:

Pharmaceutical excipients for taste masking play a crucial role in the formulation of medications, improving patient compliance by masking unpleasant tastes and odors. These excipients are used across various dosage forms, including tablets, syrups, and powders, to enhance the palatability of pharmaceutical products. The market caters to pharmaceutical manufacturers, contract research organizations (CROs), and contract manufacturing organizations (CMOs), offering a range of excipients including flavoring agents, sweeteners, and coating materials.

Market Growth Drivers:

The global pharmaceutical excipients for taste masking market is propelled by several key factors, including the rising demand for pediatric and geriatric medicines, which require effective taste masking solutions to improve patient adherence. Increased consumer preference for orally administered medications and advancements in excipient technologies, such as the development of new flavor-masking agents and advanced coating materials, further drive market expansion. The growth of the over-the-counter (OTC) pharmaceutical sector and the increasing focus on personalized medicine also contribute to the demand for innovative taste masking solutions.

Market Restraints:

Despite promising growth prospects, the pharmaceutical excipients for taste masking market faces challenges related to the high cost of advanced excipient technologies and regulatory hurdles. Stringent regulations governing the safety and efficacy of excipients impose compliance burdens on manufacturers and increase operational costs. Additionally, the limited availability of taste masking solutions for certain drug formulations and the need for continuous R&D investments to develop novel excipients pose challenges for market penetration.

Market Opportunities:

The pharmaceutical excipients for taste masking market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving pharmaceutical formulations. The integration of advanced technologies, such as nanotechnology and polymer-based excipients, enhances taste masking effectiveness and opens new avenues for market growth. Furthermore, the expanding pharmaceutical industry in emerging markets and the increasing emphasis on patient-centric drug development offer opportunities for market players to introduce cost-effective and efficient taste masking solutions. Strategic partnerships, investments in R&D, and the introduction of user-friendly excipients are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic taste masking landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the pharmaceutical excipients for taste masking market globally?
  • Which excipient types and applications are driving taste masking adoption across different pharmaceutical formulations?
  • How are technological advancements reshaping the competitive landscape of the pharmaceutical excipients for taste masking market?
  • Who are the key players contributing to the pharmaceutical excipients for taste masking market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global pharmaceutical excipients for taste masking market?

Competitive Intelligence and Business Strategy:

Leading players in the global pharmaceutical excipients for taste masking market, including Ashland Global Holdings Inc., BASF SE, and DOW Chemical Company, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced taste masking solutions, including novel flavor-masking agents and advanced coating materials, catering to diverse pharmaceutical needs and patient requirements. Collaborations with pharmaceutical manufacturers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving taste masking landscape.

Key Companies Profiled:

  • Ashland Global Holdings Inc.
  • BASF SE
  • DOW Chemical Company
  • Colorcon Inc.
  • Ingredion Incorporated
  • Roquette Freres
  • JRS Pharma
  • Lonza Group
  • Evonik Industries AG
  • Sensient Technologies Corporation

Key Segments Covered in Pharmaceutical Excipients for Taste Masking Industry Research

Excipient:

  • Natural
  • Artificial
  • Nutritive
  • Non- nutritive
  • Polyols

Technique:

  • Hot Melt Extrusion
  • Microencapsulation
  • Coating
  • Organoleptic Methods

Usage:

  • Solid Dosage Forms
  • Liquid Dosage Forms

End-User:

  • Pharmaceuticals
  • Nutraceuticals
  • Contract Manufacturing Organizations

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Excipient Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. Pipeline Assessment
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Regulatory Scenario

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Excipient Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Geriatric Population
    • 5.2.2. Technological Advancements
    • 5.2.3. Adoption of Medicine for Paediatric Population
    • 5.2.4. Increasing Chronic Diseases
    • 5.2.5. Increasing Demand of Oral and Patients Compatible Medicines
    • 5.2.6. Growth of The Top Companies
    • 5.2.7. Mergers and Acquisitions
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Excipient
    • 6.1.2. By Technique
    • 6.1.3. By Usage
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Excipient

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Excipient, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Excipient, 2024-2033
    • 8.3.1. Natural
    • 8.3.2. Artificial
    • 8.3.3. Nutritive
    • 8.3.4. Non- nutritive
    • 8.3.5. Polyols
    • 8.3.6. Others
  • 8.4. Market Attractiveness Analysis By Excipient

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Technique

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Technique, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2024-2033
    • 9.3.1. Hot Melt Extrusion
    • 9.3.2. Microencapsulation
    • 9.3.3. Coating
    • 9.3.4. Organoleptic Methods
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis By Technique

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Usage

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Usage, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2024-2033
    • 10.3.1. Solid Dosage Forms
      • 10.3.1.1. Tablets
      • 10.3.1.2. Granules
      • 10.3.1.3. Capsules
    • 10.3.2. Liquid Dosage Forms
  • 10.4. Market Attractiveness Analysis By Usage

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Pharmaceuticals
    • 11.3.2. Nutraceuticals
    • 11.3.3. Contract Manufacturing Organizations
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Excipient
    • 13.3.3. By Technique
    • 13.3.4. By Usage
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Excipient
    • 13.4.3. By Technique
    • 13.4.4. By Usage
    • 13.4.5. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. U.S. Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Excipient
        • 13.5.1.2.2. By Technique
        • 13.5.1.2.3. By Usage
        • 13.5.1.2.4. By End User
    • 13.5.2. Canada Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Excipient
        • 13.5.2.2.2. By Technique
        • 13.5.2.2.3. By Usage
        • 13.5.2.2.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Technique
    • 14.3.3. By Usage
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Excipient
    • 14.4.3. By Technique
    • 14.4.4. By Usage
    • 14.4.5. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Brazil Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Excipient
        • 14.5.1.2.2. By Technique
        • 14.5.1.2.3. By Usage
        • 14.5.1.2.4. By End User
    • 14.5.2. Mexico Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Excipient
        • 14.5.2.2.2. By Technique
        • 14.5.2.2.3. By Usage
        • 14.5.2.2.4. By End User
    • 14.5.3. Argentina Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Excipient
        • 14.5.3.2.2. By Technique
        • 14.5.3.2.3. By Usage
        • 14.5.3.2.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. France
      • 15.3.1.3. Italy
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. Russia
      • 15.3.1.7. BENELUX
      • 15.3.1.8. Nordic Countries
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Excipient
    • 15.3.3. By Technique
    • 15.3.4. By Usage
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Excipient
    • 15.4.3. By Technique
    • 15.4.4. By Usage
    • 15.4.5. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. Germany Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Excipient
        • 15.5.1.2.2. By Technique
        • 15.5.1.2.3. By Usage
        • 15.5.1.2.4. By End User
    • 15.5.2. France Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Excipient
        • 15.5.2.2.2. By Technique
        • 15.5.2.2.3. By Usage
        • 15.5.2.2.4. By End User
    • 15.5.3. Italy Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Excipient
        • 15.5.3.2.2. By Technique
        • 15.5.3.2.3. By Usage
        • 15.5.3.2.4. By End User
    • 15.5.4. U.K. Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Excipient
        • 15.5.4.2.2. By Technique
        • 15.5.4.2.3. By Usage
        • 15.5.4.2.4. By End User
    • 15.5.5. Spain Market Analysis
      • 15.5.5.1. Introduction
      • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.5.2.1. By Excipient
        • 15.5.5.2.2. By Technique
        • 15.5.5.2.3. By Usage
        • 15.5.5.2.4. By End User
    • 15.5.6. Russia Market Analysis
      • 15.5.6.1. Introduction
      • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.6.2.1. By Excipient
        • 15.5.6.2.2. By Technique
        • 15.5.6.2.3. By Usage
        • 15.5.6.2.4. By End User
    • 15.5.7. Nordic Countries Market Analysis
      • 15.5.7.1. Introduction
      • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.7.2.1. By Excipient
        • 15.5.7.2.2. By Technique
        • 15.5.7.2.3. By Usage
        • 15.5.7.2.4. By End User
    • 15.5.8. BENELUX Market Analysis
      • 15.5.8.1. Introduction
      • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.8.2.1. By Excipient
        • 15.5.8.2.2. By Technique
        • 15.5.8.2.3. By Usage
        • 15.5.8.2.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Thailand
      • 16.3.1.3. Indonesia
      • 16.3.1.4. Malaysia
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Excipient
    • 16.3.3. By Technique
    • 16.3.4. By Usage
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Excipient
    • 16.4.3. By Technique
    • 16.4.4. By Usage
    • 16.4.5. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. India Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Excipient
        • 16.5.1.2.2. By Technique
        • 16.5.1.2.3. By Usage
        • 16.5.1.2.4. By End User
    • 16.5.2. Thailand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Excipient
        • 16.5.2.2.2. By Technique
        • 16.5.2.2.3. By Usage
        • 16.5.2.2.4. By End User
    • 16.5.3. Indonesia Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Excipient
        • 16.5.3.2.2. By Technique
        • 16.5.3.2.3. By Usage
        • 16.5.3.2.4. By End User
    • 16.5.4. Malaysia Market Analysis
      • 16.5.4.1. Introduction
      • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.4.2.1. By Excipient
        • 16.5.4.2.2. By Technique
        • 16.5.4.2.3. By Usage
        • 16.5.4.2.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Excipient
    • 17.3.3. By Technique
    • 17.3.4. By Usage
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Excipient
    • 17.4.3. By Technique
    • 17.4.4. By Usage
    • 17.4.5. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. China Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Excipient
        • 17.5.1.2.2. By Technique
        • 17.5.1.2.3. By Usage
        • 17.5.1.2.4. By End User
    • 17.5.2. Japan Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Excipient
        • 17.5.2.2.2. By Technique
        • 17.5.2.2.3. By Usage
        • 17.5.2.2.4. By End User
    • 17.5.3. South Korea Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Excipient
        • 17.5.3.2.2. By Technique
        • 17.5.3.2.3. By Usage
        • 17.5.3.2.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Excipient
    • 18.3.3. By Technique
    • 18.3.4. By Usage
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Excipient
    • 18.4.3. By Technique
    • 18.4.4. By Usage
    • 18.4.5. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. Australia Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Excipient
        • 18.5.1.2.2. By Technique
        • 18.5.1.2.3. By Usage
        • 18.5.1.2.4. By End User
    • 18.5.2. New Zealand Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Excipient
        • 18.5.2.2.2. By Technique
        • 18.5.2.2.3. By Usage
        • 18.5.2.2.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. Northern Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Excipient
    • 19.3.3. By Technique
    • 19.3.4. By Usage
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Excipient
    • 19.4.3. By Technique
    • 19.4.4. By Usage
    • 19.4.5. By End User
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. GCC Countries Market Analysis
      • 19.5.1.1. Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Excipient
        • 19.5.1.2.2. By Technique
        • 19.5.1.2.3. By Usage
        • 19.5.1.2.4. By End User
    • 19.5.2. Turkiye Market Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Excipient
        • 19.5.2.2.2. By Technique
        • 19.5.2.2.3. By Usage
        • 19.5.2.2.4. By End User
    • 19.5.3. Northern Africa Market Analysis
      • 19.5.3.1. Introduction
      • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.3.2.1. By Excipient
        • 19.5.3.2.2. By Technique
        • 19.5.3.2.3. By Usage
        • 19.5.3.2.4. By End User
    • 19.5.4. South Africa Market Analysis
      • 19.5.4.1. Introduction
      • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.4.2.1. By Excipient
        • 19.5.4.2.2. By Technique
        • 19.5.4.2.3. By Usage
        • 19.5.4.2.4. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Branding and Promotional Strategies
  • 21.3. Key Development Analysis
  • 21.4. Competition Deep Dive
    • 21.4.1. SPI Pharma, Inc.
      • 21.4.1.1. Overview
      • 21.4.1.2. Excipient Portfolio
      • 21.4.1.3. Key financials
      • 21.4.1.4. Sales Footprint
      • 21.4.1.5. Strategy Overview
        • 21.4.1.5.1. Marketing Strategy
        • 21.4.1.5.2. Product Strategy
        • 21.4.1.5.3. Channel Strategy
    • 21.4.2. Adare Pharmaceutical Inc.
      • 21.4.2.1. Overview
      • 21.4.2.2. Excipient Portfolio
      • 21.4.2.3. Key financials
      • 21.4.2.4. Sales Footprint
      • 21.4.2.5. Strategy Overview
        • 21.4.2.5.1. Marketing Strategy
        • 21.4.2.5.2. Product Strategy
        • 21.4.2.5.3. Channel Strategy
    • 21.4.3. GPT Pharmaceuticals Pvt. Ltd
      • 21.4.3.1. Overview
      • 21.4.3.2. Excipient Portfolio
      • 21.4.3.3. Key financials
      • 21.4.3.4. Sales Footprint
      • 21.4.3.5. Strategy Overview
        • 21.4.3.5.1. Marketing Strategy
        • 21.4.3.5.2. Product Strategy
        • 21.4.3.5.3. Channel Strategy
    • 21.4.4. Roquette Freres
      • 21.4.4.1. Overview
      • 21.4.4.2. Excipient Portfolio
      • 21.4.4.3. Key financials
      • 21.4.4.4. Sales Footprint
      • 21.4.4.5. Strategy Overview
        • 21.4.4.5.1. Marketing Strategy
        • 21.4.4.5.2. Product Strategy
        • 21.4.4.5.3. Channel Strategy
    • 21.4.5. Rochem International, Inc.
      • 21.4.5.1. Overview
      • 21.4.5.2. Excipient Portfolio
      • 21.4.5.3. Key financials
      • 21.4.5.4. Sales Footprint
      • 21.4.5.5. Strategy Overview
        • 21.4.5.5.1. Marketing Strategy
        • 21.4.5.5.2. Product Strategy
        • 21.4.5.5.3. Channel Strategy
    • 21.4.6. Gattefose
      • 21.4.6.1. Overview
      • 21.4.6.2. Excipient Portfolio
      • 21.4.6.3. Key financials
      • 21.4.6.4. Sales Footprint
      • 21.4.6.5. Strategy Overview
        • 21.4.6.5.1. Marketing Strategy
        • 21.4.6.5.2. Product Strategy
        • 21.4.6.5.3. Channel Strategy
    • 21.4.7. Asahi Kasei Corporation
      • 21.4.7.1. Overview
      • 21.4.7.2. Excipient Portfolio
      • 21.4.7.3. Key financials
      • 21.4.7.4. Sales Footprint
      • 21.4.7.5. Strategy Overview
        • 21.4.7.5.1. Marketing Strategy
        • 21.4.7.5.2. Product Strategy
        • 21.4.7.5.3. Channel Strategy
    • 21.4.8. DuPont de Nemours, Inc
      • 21.4.8.1. Overview
      • 21.4.8.2. Excipient Portfolio
      • 21.4.8.3. Key financials
      • 21.4.8.4. Sales Footprint
      • 21.4.8.5. Strategy Overview
        • 21.4.8.5.1. Marketing Strategy
        • 21.4.8.5.2. Product Strategy
        • 21.4.8.5.3. Channel Strategy
    • 21.4.9. Dow Pharma Solutions
      • 21.4.9.1. Overview
      • 21.4.9.2. Excipient Portfolio
      • 21.4.9.3. Key financials
      • 21.4.9.4. Sales Footprint
      • 21.4.9.5. Strategy Overview
        • 21.4.9.5.1. Marketing Strategy
        • 21.4.9.5.2. Product Strategy
        • 21.4.9.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology